MEDIKRA
LIVE

Serial Number

99311617

Owner

Medikra Inc.

Attorney

OTTO O. LEE

Filing Date

Jul 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MEDIKRA Trademark

Serial Number: 99311617

MEDIKRA is a trademark filed by Medikra Inc. on July 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Medikra Inc.

4th Floor, Harbour Place, 103 South Church Street
Grand Cayman KY1-1002 , KY

Entity Type: 11

Trademark Details

Filing Date

July 30, 2025

Registration Date

Not Registered

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemical preparations for medical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemico-pharmaceutical preparations, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; dietetic preparations adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; medical preparations for slimming purposes; pharmaceutical preparations; pharmaceuticals for the treatment and prevention of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases; medicinal preparations for the mouth to be applied in the form of softgels or gelatine capsules, capsules, tablets or compressed tablets; medicinal health care preparations, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; medicinal herbal extracts other than essential oils, for medical purposes; herbal medicine, namely, medicinal herbal preparations; herbal supplements; herbal remedies namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; plant and herb extracts other than essential oils for medicinal purposes; plant extracts other than essential oils for pharmaceutical purposes; capsules sold empty for medicines; dietary food supplements consisting of dehydrated herbal extracts in capsule form

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2025 NWOS
NEW APPLICATION ENTERED
Jul 30, 2025 NWAP